首页> 外国专利> Resistance to fracture an oral pharmaceutical dosage form comprising a pharmacologically active ingredient opioid antagonist and / or a means, is disgusting, polyalkylene oxide and anionic polymers

Resistance to fracture an oral pharmaceutical dosage form comprising a pharmacologically active ingredient opioid antagonist and / or a means, is disgusting, polyalkylene oxide and anionic polymers

机译:抗断裂的口服药物剂型,其包含药理活性成分阿片样物质拮抗剂和/或手段,令人恶心,聚环氧烷和阴离子聚合物

摘要

The invention relates to a pharmaceutical dosage form for oral administration, which has a tensile strength of at least 300 N and which contains (I) a pharmacologically active ingredient; (Ii) an opioid antagonist and / or aversion agent; (Iii) a polyalkylene oxide that has an average molecular weight of at least 200,000 g / mol; and (a) which contains (IV) an anionic polymer and / or (b) has storage stability at 40 ° C. for at least 3 months.
机译:本发明涉及口服给药的药物剂型,其具有至少300N的拉伸强度并且包含(I)药理活性成分; (ii)阿片类拮抗剂和/或厌恶剂; (Iii)平均分子量为至少200,000 g / mol的聚环氧烷; (a)含有(IV)阴离子聚合物和/或(b)在40℃下至少3个月的保存稳定性。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号